Skip to main content
. 2016 May 25;128:397–403. doi: 10.1007/s00508-016-1004-y

Table 1.

Demographic data and trauma severity of the study population

Cohort p value (ET vs TR)
ET ET, then TR Total ANOVA Kruskal–Wallis
Patients, n (%) 1,603 (74) 553 (26) 2,156 (100)
Age (years; median IQR) 58 (40–74) 62 (47–75) 59 (42–74) 0.004
Sex
Male, n (%) 1,167 (73) 394 (71) 1,561 (72) 0.49
Female, n (%) 434 (27) 158 (29) 592 (28) 0.49
AIS head score, n (%)
2 85 (5.3) 8 (1.5) 93 (4.3) < 0.001
3 300 (18.7) 88 (15.9) 388 (18.0) 0.14
4 636 (39.7) 257 (46.5) 893 (41.4) 0.005
5 582 (36.3) 200 (36.1) 782 (36.3) 0.95
GCS score, median (IQR) 6 (3–8) 6 (3–8) 6 (3–8) 0.90
SAPS II, median (IQR) 45 (36–56) 45 (35–56) 45 (37–54) 0.86
No comorbidity, n (%) 1,146 (72) 378 (68) 1,524 (71) 0.16
Mortality predicted by SAPS II, % 40 38 39 0.86

AIS  Abbreviated Injury Scale, ANOVA analysis of variance, CI confidence interval, ET endotracheal tube, GCS Glasgow Coma Scale score, IQR interquartile range, SAPS Simplified Acute Physiology Score, TISS Therapeutic Intervention Scoring System, TR tracheostomy